Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Good

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
Immunology Letters|August 1, 1990
Peptide analysis of the T cell response to the malaria circumsporozoite (CS) proteinM F Good, Y Zevering
Memorias Do Instituto Oswaldo Cruz|January 1, 1992
Plasmodium falciparum CS protein--prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variationD L Doolan, M F Good
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1983
Clones of cytotoxic T lymphocytes reactive to haptenated allogeneic cells: precursor frequency and characteristics as determined by a split-culture approachM F Good, G J Nossal
Journal of Immunological Methods|July 30, 1982
A method for the accurate determination of anti-hapten cytotoxic T lymphocyte precursors: correction for apparent 'anti-self' reactivityM F Good, G J Nossal
Current Topics in Microbiology and Immunology|January 1, 1990
T-cell antigens and epitopes in malaria vaccine designM F Good, L H Miller
Current Opinion in Immunology|August 17, 1999
Immune effector mechanisms in malariaM F Good, D L Doolan
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell toleranceM F Good, G J Nossal
Vaccine|April 1, 1988
The main obstacle to a malaria vaccine: the malaria parasiteL H Miller, M F Good
Current Protocols in Immunology|April 25, 2008
Experimental asexual blood stage malaria immunityF H Amante, M F Good
Vaccine|February 1, 1989
Involvement of T cells in malaria immunity: implications for vaccine developmentM F Good, L H Miller
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Immunology Letters|August 1, 1990
Peptide analysis of the T cell response to the malaria circumsporozoite (CS) proteinM F Good, Y Zevering
Memorias Do Instituto Oswaldo Cruz|January 1, 1992
Plasmodium falciparum CS protein--prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variationD L Doolan, M F Good
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1983
Clones of cytotoxic T lymphocytes reactive to haptenated allogeneic cells: precursor frequency and characteristics as determined by a split-culture approachM F Good, G J Nossal
Journal of Immunological Methods|July 30, 1982
A method for the accurate determination of anti-hapten cytotoxic T lymphocyte precursors: correction for apparent 'anti-self' reactivityM F Good, G J Nossal
Current Topics in Microbiology and Immunology|January 1, 1990
T-cell antigens and epitopes in malaria vaccine designM F Good, L H Miller
Current Opinion in Immunology|August 17, 1999
Immune effector mechanisms in malariaM F Good, D L Doolan
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell toleranceM F Good, G J Nossal
Vaccine|April 1, 1988
The main obstacle to a malaria vaccine: the malaria parasiteL H Miller, M F Good
Current Protocols in Immunology|April 25, 2008
Experimental asexual blood stage malaria immunityF H Amante, M F Good
Vaccine|February 1, 1989
Involvement of T cells in malaria immunity: implications for vaccine developmentM F Good, L H Miller
Pageof 16